We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$1.44B
AUM Growth
-$266M
Cap. Flow
-$4.59M
Cap. Flow %
-0.32%
Top 10 Hldgs %
33.34%
Holding
325
New
10
Increased
75
Reduced
47
Closed
24

Top Buys

Rank Stock Value
1
BURL icon
Burlington
BURL
+$598K
2
TFX icon
Teleflex
TFX
+$547K
3
GDDY icon
GoDaddy
GDDY
+$471K
4
BMY icon
Bristol-Myers Squibb
BMY
+$452K
5
XMTR icon
Xometry
XMTR
+$416K

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$999K
2
C icon
Citigroup
C
+$675K
3
WRB icon
W.R. Berkley
WRB
+$655K
4
CSL icon
Carlisle Companies
CSL
+$506K
5
WSC icon
WillScot Mobile Mini Holdings
WSC
+$502K

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Industrials 16.41%
3 Healthcare 12.77%
4 Financials 11.85%
5 Communication Services 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
201
Boston Scientific
BSX
$67.9B
$328K 0.02%
8,805
– –
VTRS icon
202
Viatris
VTRS
$18.8B
$325K 0.02%
31,019
– –
KAI icon
203
Kadant
KAI
$3.57B
$325K 0.02%
1,780
– –
EWJ icon
204
iShares MSCI Japan ETF
EWJ
$22.7B
$321K 0.02%
6,078
-1,390
-19% -$78.5K
RPD icon
205
Rapid7
RPD
$896M
$319K 0.02%
4,780
– –
ICLR icon
206
Icon
ICLR
$13.1B
$319K 0.02%
1,472
– –
ABM icon
207
ABM Industries
ABM
$2.77B
$319K 0.02%
7,336
– –
LIN icon
208
Linde
LIN
$226B
$315K 0.02%
1,095
-354
-24% -$111K
WOR icon
209
Worthington Enterprises
WOR
$2.8B
$312K 0.02%
11,487
+1,041
+10% +$30.2K
APLS
210
DELISTED
Apellis Pharmaceuticals
APLS
$312K 0.02%
6,892
+1,123
+19% +$51.2K
BMO icon
211
Bank of Montreal
BMO
$120B
$311K 0.02%
3,231
– –
AMX icon
212
America Movil
AMX
$69.4B
$307K 0.02%
15,019
-4,114
-22% -$84.6K
ESNT icon
213
Essent Group
ESNT
$6.19B
$306K 0.02%
7,874
– –
PLD icon
214
Prologis
PLD
$134B
$305K 0.02%
2,589
+747
+41% +$103K
NGG icon
215
National Grid
NGG
$79.8B
$304K 0.02%
5,077
+445
+10% +$29.4K
PG icon
216
Procter & Gamble
PG
$334B
$304K 0.02%
+2,116
New +$318K
UCB
217
United Community Banks
UCB
$4.24B
$303K 0.02%
10,043
– –
SUM
218
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$302K 0.02%
13,169
+3,088
+31% +$82K
SHW icon
219
Sherwin-Williams
SHW
$83.7B
$301K 0.02%
1,343
+139
+12% +$35.7K
COHR icon
220
Coherent
COHR
$54.7B
$298K 0.02%
5,855
– –
SLAB icon
221
Silicon Laboratories
SLAB
$7.29B
$297K 0.02%
2,116
– –
CCEP icon
222
Coca-Cola Europacific Partners
CCEP
$48.2B
$294K 0.02%
5,705
+366
+7% +$18.7K
FOLD
223
DELISTED
Amicus Therapeutics
FOLD
$294K 0.02%
27,361
– –
VMRK
224
Vivmark Residential
VMRK
$26.1B
$294K 0.02%
4,065
– –
DOC
225
DELISTED
PHYSICIANS REALTY TRUST
DOC
$293K 0.02%
16,814
– –
7 8
9
10 11

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Henshaw Capital held 325 positions worth $1.44B, down 16% from $1.71B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Henshaw Capital's Q2 2022 filing shows 10 new, 75 increased, 47 reduced and 24 closed positions. Its largest new stake was Bristol-Myers Squibb: 5,930 shares worth $457K. The largest sale was Dentsply Sirona, an estimated $999K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Henshaw Capital's largest Q2 2022 buy was Bristol-Myers Squibb: 5,930 shares worth $457K.
  • Henshaw Capital added most to Burlington in Q2 2022, an estimated $598K increase.
  • Henshaw Capital's biggest Q2 2022 reduction was Citigroup, cutting an estimated $675K.
  • Henshaw Capital fully exited Dentsply Sirona in Q2 2022, selling an estimated $999K.
  • Henshaw Capital's ten largest holdings make up 33% of its $1.44B portfolio in Q2 2022.
  • Henshaw Capital opened 10 new positions and closed 24 in Q2 2022.
  • Henshaw Capital's portfolio value fell 16% quarter-over-quarter to $1.44B.

Based on Henshaw Capital's 13F filing for Q2 2022, filed 28 May 2026.